What type of study is this?

October 18, 2025Hypertension

Semaglutide and Blood Pressure Changes in Patients with Cardiometabolic Conditions

View Full Paper

Ask AI

Bookmark

Semaglutide use was associated with a 6.3 mmHg reduction in systolic blood pressure.
In a cohort of 266 adults, those on semaglutide had lower baseline blood pressure compared to those unexposed.
Models adjusted for sociodemographic factors indicated significant systolic blood pressure reductions post semaglutide use.
Findings support semaglutide’s role in reducing cardiovascular risk for patients with hypertension and diabetes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective cohort study reveals semaglutide may lower blood pressure in patients with hypertension and diabetes, suggesting its potential cardiovascular benefits.

Cite This Study

Vassiliadi et al. (2025) studied this question.

synapsesocial.com/papers/68f3b2fb3f213c1f8b4d36dc https://doi.org/10.1161/hyp.82.suppl_1.018

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study reveals semaglutide may lower blood pressure in patients with hypertension and diabetes, suggesting its potential cardiovascular benefits.

Semaglutide and Blood Pressure Changes in Patients with Cardiometabolic Conditions

Key Points

Discussion

Implication

Cite This Study

Semaglutide and Blood Pressure Changes in Patients with Cardiometabolic Conditions

Key Points

Discussion

Implication

Cite This Study